Suppr超能文献

内脏肥胖在食管鳞状细胞癌患者中的意义。

Implication of visceral obesity in patients with esophageal squamous cell carcinoma.

作者信息

Okamura Akihiko, Watanabe Masayuki, Yamashita Kotaro, Yuda Masami, Hayami Masaru, Imamura Yu, Mine Shinji

机构信息

Department of Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

出版信息

Langenbecks Arch Surg. 2018 Mar;403(2):245-253. doi: 10.1007/s00423-017-1643-0. Epub 2017 Dec 2.

Abstract

PURPOSE

Visceral obesity is considered to be associated not only with chronic systemic inflammation but also with aggressive cancer behavior. However, the implication of visceral obesity in patients with esophageal squamous cell carcinoma (ESCC) is unclear.

METHODS

Computed tomography volumetry was performed in 364 patients who underwent esophagectomy for ESCC. We calculated the ratio of the visceral fat area to the subcutaneous fat area (VS ratio), which is a valuable parameter of visceral obesity. Then, the clinicopathological characteristics were compared between patients with low VS ratio and those with high VS ratio.

RESULTS

Overall and disease-specific survivals of patients with high VS ratio were significantly worse than those with low VS ratio (P < 0.001 in both). Patients with high VS ratio had considerably more advanced pN factor, higher prevalence of lymphatic invasion, and more number of metastatic lymph nodes than those with low VS ratio (P = 0.044, < 0.001, and 0.006, respectively). Among patients who received preoperative treatment, high VS ratio correlated with poor response to preoperative treatment (P = 0.040).

CONCLUSIONS

Visceral obesity was associated with lymphatic invasiveness and poor response to preoperative treatment in patients with ESCC, which may negatively influence their prognosis.

摘要

目的

内脏肥胖不仅被认为与慢性全身炎症有关,还与侵袭性癌症行为有关。然而,内脏肥胖在食管鳞状细胞癌(ESCC)患者中的意义尚不清楚。

方法

对364例行ESCC食管切除术的患者进行计算机断层扫描容积测量。我们计算了内脏脂肪面积与皮下脂肪面积之比(VS比),这是内脏肥胖的一个重要参数。然后,比较了低VS比患者和高VS比患者的临床病理特征。

结果

高VS比患者的总生存期和疾病特异性生存期明显低于低VS比患者(两者P均<0.001)。高VS比患者的pN因子进展程度更高,淋巴侵犯发生率更高,转移淋巴结数量也比低VS比患者更多(P分别为0.044、<0.001和0.006)。在接受术前治疗的患者中,高VS比与术前治疗反应差相关(P = 0.040)。

结论

内脏肥胖与ESCC患者的淋巴侵袭性和术前治疗反应差有关,这可能对其预后产生负面影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验